Gunn, Robin J.
Mirati Therapeutics (United States)
2 papers on CoChatORCID 0000-0003-0865-0369
Most cited papers
- Verified
Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS G12D Inhibitor
Wang, X., Allen, S., Blake, J. F., Bowcut, V., Briere, D. M., Calinisan, A., Dahlke, J. R., Fell, J. B., Fischer, J. P., Gunn, R. J., et al. (2022) · Journal of Medicinal Chemistry
Protein Kinase Regulation and GTPase SignalingProtein Tyrosine Phosphatases
Cited by 769
- Verified
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
Hallin, J., Bowcut, V., Calinisan, A., Briere, D. M., Hargis, L., Engstrom, L. D., Laguer, J., Medwid, J., Vanderpool, D., Lifset, E., et al. (2022) · Nature Medicine
Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways
Cited by 553
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free